Randomized trial of a comparison of the efficacy of TVT-O and single-incision tape TVT SECUR systems in the treatment of stress urinary incontinent women--2-year follow-up
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, randomizované kontrolované studie, práce podpořená grantem
- MeSH
- gynekologické chirurgické výkony metody MeSH
- kašel MeSH
- lidé středního věku MeSH
- lidé MeSH
- longitudinální studie MeSH
- následné studie MeSH
- neúspěšná terapie MeSH
- průzkumy a dotazníky MeSH
- senioři MeSH
- stresová inkontinence moči chirurgie MeSH
- suburetrální pásky * MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
INTRODUCTION AND HYPOTHESIS: The aim of this study was to compare the efficacy of the use of tension-free vaginal tape obturator (TVT-O) and single-incision TVT SECUR, hammock and U approach (TVT-S, H and U), in the treatment of urodynamic stress urinary incontinence (SUI). METHODS: This single-center randomized three-arm trial compared the objective and subjective efficacy and early failure rate of the TVT-O and TVT-S H and U approach by objective criteria (cough test) and subjective criteria using the International Consultation on Incontinence Questionnaire--Short Form (ICIQ-UI SF). The objective efficacy rate was defined as the number of patients with a negative cough stress test. Subjective cure was defined by no stress leakage of urine after surgery based on the evaluation of ICIQ-UI SH (when patients ticked "Never"/"Urine does not leak" in answer to question 6: When does urine leak?). Objective and subjective efficacy were evaluated using Last Failure Carried Forward analysis, i.e., final analysis also included patients with early failure. To describe outcome at different time points, the Last Observation Carried Forward method was also implemented. RESULTS: One hundred ninety-seven women with proven SUI were randomized into three groups--TVT-O (n = 68), TVT-S H (n = 64), and TVT-S U (n = 65). Each patient allocated to a treatment group received the planned surgery. There were no differences in each group in preoperative characteristics. Median follow-up after surgery was 2 years (SD, 0.8; range, 0.1 to 3.8 years). Of the subjects, 92.6% in the TVT-O group, 68.8% in the TVT-S H group, and 69.2% in the TVT-S U group had negative stress test (p < 0.001). Of the subjects, 85.3 % in the TVT-O group, 68.8% in the TVT-S H group, and 61.5% in the TVT-S U group were subjectively continent (p = 0.02). CONCLUSIONS: Our study demonstrated a significantly lower subjective and objective cure rate in the single-incision TVT group compared to the TVT-O group.
Zobrazit více v PubMed
Neurourol Urodyn. 2007;26(1):46-52 PubMed
Aust N Z J Obstet Gynaecol. 2010 Apr;50(2):168-72 PubMed
Eur Urol. 2010 Jul;58(1):157-61 PubMed
N Engl J Med. 2010 Jun 3;362(22):2066-76 PubMed
Neurourol Urodyn. 2011 Mar;30(3):284-91 PubMed
Eur Urol. 2008 Feb;53(2):288-308 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1257-61 PubMed
Eur Urol. 2010 Jun;57(6):973-9 PubMed
Obstet Gynecol. 2004 Nov;104(5 Pt 1):989-94 PubMed
Acta Obstet Gynecol Scand. 2002 Jan;81(1):72-7 PubMed
Eur Urol. 2007 Sep;52(3):663-78 PubMed
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):121-5 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Nov;19(11):1581-3 PubMed
Int J Gynaecol Obstet. 2010 Dec;111(3):233-6 PubMed
Eur Urol. 2011 Jun;59(6):940-4 PubMed
J Minim Invasive Gynecol. 2008 Jul-Aug;15(4):480-4 PubMed
Int Urogynecol J. 2010 Sep;21(9):1175-7 PubMed
J Gynecol Obstet Biol Reprod (Paris). 2009 Jun;38(4):299-303 PubMed
Obstet Gynecol. 2003 May;101(5 Pt 1):929-32 PubMed
Scand J Urol Nephrol. 1995 Mar;29(1):75-82 PubMed
Int Urogynecol J. 2011 Apr;22(4):443-5 PubMed
Int Urogynecol J. 2010 Jan;21(1):5-26 PubMed
Int Urogynecol J. 2011 Feb;22(2):241-6 PubMed
Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):232-8 PubMed
Int Urogynecol J. 2010 Jul;21(7):779-85 PubMed
Int Urogynecol J. 2010 Oct;21(10):1211-7 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Mar;20(3):313-7 PubMed
Am J Obstet Gynecol. 2008 May;198(5):546.e1-4 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2009 May;20(5):533-9 PubMed
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun;20(6):681-8 PubMed
Eur Urol. 2003 Dec;44(6):724-30 PubMed
Int Urogynecol J. 2011 Jul;22(7):781-7 PubMed
Obstet Gynecol. 2004 Dec;104(6):1259-62 PubMed
What is the optimal length for single-incision tape?
TVT ABBREVO: cadaveric study of tape position in foramen obturatum and adductor region
Fixation of the Ajust minisling based upon cadaveric study